latest news releases from the newsroom
BSD Medical Corporation
BSD Medical: TV News Coverage Reports On the Use of Hyperthermia to Treat Recurrent Cancers
SALT LAKE CITY, April 17, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported that hyperthermia treatment was highlighted in a television segment that aired on WKYC, Channel 3, Cleveland's NBC owned and operated television station. The story can be viewed at: http://www.wkyc.com/news/health/health_article.aspx?storyid=111150&catid=7 ((c) 2009 WKYC-TV). The segment features a patient who had recurrent breast cancer and was treated with radiation therapy combined with hyperthermia delivered by the BSD-500 Hyperthermia System.
Medicis Pharmaceutical Corporation
Medicis Announces New Notice of Allowance for SOLODYN(R) 90mg
SCOTTSDALE, Ariz., April 17, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the United States Patent and Trademark Office (USPTO) has issued another Notice of Allowance to Medicis for a United States patent application related to SOLODYN(R) in 90mg tablet form. For the week ending April 3, 2009, the 90mg strength represented over 60% of total SOLODYN(R) prescriptions.(1)